Chronic obstructive pulmonary disease (COPD) is a common respiratory condition where patients´ survivability strongly depends on oxygen therapy, supplemented for at least 15h daily, to facilitate breathing and improve their quality of life. Current home oxygen therapy relies on a fixed oxygen dosage that can only be adjusted manually through scarce visits of healthcare providers. This poses huge challenges to patients, as their oxygen needs can vary within seconds, and if left unadjusted can lead to dangerous clinical complications. O2m has developed a pioneer solution – Home Oxygen Therapy - that will enable for the first time an automated accurate oxygen dosage to treat COPD patients at home. Our solution will provide a more accurate oxygen dosage to the patients for much longer, leading to reduced exacerbation episodes, less hospital visits, and fewer health complications, thus significantly improving patients´ survivability, quality of life, and strongly reducing healthcare costs.